|  Help  |  About  |  Contact Us

Publication : mTORC1 stimulates phosphatidylcholine synthesis to promote triglyceride secretion.

First Author  Quinn WJ 3rd Year  2017
Journal  J Clin Invest Volume  127
Issue  11 Pages  4207-4215
PubMed ID  29035283 Mgi Jnum  J:255468
Mgi Id  MGI:6107731 Doi  10.1172/JCI96036
Citation  Quinn WJ 3rd, et al. (2017) mTORC1 stimulates phosphatidylcholine synthesis to promote triglyceride secretion. J Clin Invest 127(11):4207-4215
abstractText  Liver triacylglycerol (TAG) synthesis and secretion are closely linked to nutrient availability. After a meal, hepatic TAG formation from fatty acids is decreased, largely due to a reduction in circulating free fatty acids (FFA). Despite the postprandial decrease in FFA-driven esterification and oxidation, VLDL-TAG secretion is maintained to support peripheral lipid delivery and metabolism. The regulatory mechanisms underlying the postprandial control of VLDL-TAG secretion remain unclear. Here, we demonstrated that the mTOR complex 1 (mTORC1) is essential for this sustained VLDL-TAG secretion and lipid homeostasis. In murine models, the absence of hepatic mTORC1 reduced circulating TAG, despite hepatosteatosis, while activation of mTORC1 depleted liver TAG stores. Additionally, mTORC1 promoted TAG secretion by regulating phosphocholine cytidylyltransferase alpha (CCTalpha), the rate-limiting enzyme involved in the synthesis of phosphatidylcholine (PC). Increasing PC synthesis in mice lacking mTORC1 rescued hepatosteatosis and restored TAG secretion. These data identify mTORC1 as a major regulator of phospholipid biosynthesis and subsequent VLDL-TAG secretion, leading to increased postprandial TAG secretion.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

9 Bio Entities

Trail: Publication

0 Expression